Secondary immune response to tetanus toxoid in psychiatric patients
References (26)
- et al.
Genetic and stress factors affecting the abnormal lymphocyte in schizophrenia
J. psychiat. Res.
(1965) - et al.
Schizophrenia as a specific biologic disease
Am. J. Psychiat.
(1968) - et al.
Electrophoretic and analytical ultracentrifuge studies in sera of psychotic patients: Elevation of gammaglobulins and macroglobulins and splitting of alpha2 globulins
Ann. intern. Med.
(1961) Macroglobulin elevations in functional mental illness
Nature, Lond.
(1962)- et al.
Abnormal leukocytes in schizophrenia
Archs gen. Psychiat.
(1963) Atypical leukocyte pattern of schizophrenic children
Archs gen. Psychiat.
(1968)‘Antibrain’ factors in psychiatric patients' sera—I. Further studies with hemagglutination technique
Archs gen. Psychiat.
(1963)Disturbed serum proteins in chronic psychosis
Archs gen. Psychiat.
(1961)Are autoimmune diseases immunologic deficiency states?
Hosp. Prac.
(1968)- et al.
Experimental glomerulonephritis
J. exp. Med.
(1961)
Emotions, immunity and disease: a speculative theoretical integration
Archs gen. Psychiat.
Globulins and behavior in schizophrenia
Int. J. Neuropsychiat.
Immunoglobulins in psychiatric patients
Archs gen. Psychiat.
Cited by (5)
Immune response to vaccination in adults with mental disorders: A systematic review
2022, Journal of Affective DisordersCitation Excerpt :The publication years for included studies is also a potential cause for concern, as only one (Wang et al., 2016) of the five studies on schizophrenia in this review was conducted after 1972. The remaining four studies (Hussar et al., 1971; Solomon et al., 1968; Friedman et al., 1967; Vaughan et al., 1949) were thus written prior to the development of increasingly rigorous diagnostic criteria through the DSM-III, which was published in 1980 (American Psychiatric Association, 2022) and was considered a turning point in the conceptualization of psychiatric disorders, particularly schizophrenia (Jablensky, 2010). Following the introduction of the DSM-IV in 1994 (American Psychiatric Association, 2022) and the ICD-10 in 1990 (World Health Organization), the reliability of psychiatrists' schizophrenia diagnoses is also considered to have improved (Jablensky. 2010).
Psychotropic drugs interaction with the lipid nanoparticle of COVID-19 mRNA therapeutics
2022, Frontiers in PharmacologyClozapine-associated secondary antibody deficiency
2019, Current Opinion in Allergy and Clinical ImmunologyAutoantibodies to brain and polynucleotides in patients with schizophrenia: A puzzle
1992, Immunologic ResearchImmunoglobulins and Improvement in Acute Schizophrenic Reactions
1973, Archives of General Psychiatry
- §
For clinical portions of this work.
- ⌈
For laboratory portions of this work.
- ∗
Department of Psychiatry, Stanford University School of Medicine, Stanford, California.
- †
Deceased.